Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01800045Phase 3Completed
A Phase 3 trial of pitolisant in Narcolepsy type 1 (NT1), sponsored by Bioprojet. Started Apr 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01800045.